Authors
Loading...
Review uncovers diverse atherogenic lipoprotein particles driving cardiovascular risk beyond standard low-density lipoprotein, highlighting potential targets for precision coronary disease therapies.
Carmena et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: